Clinical Trial of Dopamine-Serotonin Medication Combination in Cocaine Dependence

$244,985P50FY2010DANIH

University Of Texas Hlth Sci Ctr Houston, Houston TX

Investigators

Linked publications & trials

Paper 37344702 Paper 36971714 Paper 36614248 Paper 34994673 Paper 34923324 Paper 34600245 Paper 33119414 Paper 33021143 Paper 32593950 Paper 32267062 Paper 31958903 Paper 31927220 Paper 31631955 Paper 31176066 Paper 30968959 Paper 30625144 Paper 30472571 Paper 30418104 Paper 30408130 Paper 29771557 Paper 29287668 Paper 28498501 Paper 28192722 Paper 27862692 Paper 27646197 Paper 27022201 Paper 27014100 Paper 26693170 Paper 26681735 Paper 26566718 Paper 26512421 Paper 26484829 Paper 26241153 Paper 26170765 Paper 26164486 Paper 26110342 Paper 26082893 Paper 25841982 Paper 25662909 Paper 25414797 Paper 25336321 Paper 25299617 Paper 25134057 Paper 24809448 Paper 24621090 Paper 24618688 Paper 24582546 Paper 24512640 Paper 24507117 Paper 24424425 Paper 24029622 Paper 24026715 Paper 23761390 Paper 23588313 Paper 23549451 Paper 23371492 Paper 23151990 Paper 22969732 Paper 22905331 Paper 22654774 Paper 22464943 Paper 22425411 Paper 22047976 Paper 21730016 Paper 21692148 Paper 21204739 Paper 21172570 Paper 20661285 Paper 20570057 Paper 20545388 Paper 20478631 Paper 20155594 Paper 20153142 Paper 19595517 Paper 19462304 Paper 19353809 Paper 19322730 Paper 19217266 Paper 19058926 Paper 18164144 Paper 18093749 Paper 17994474 Paper 17613964 Paper 17543472 Paper 17321725 Paper 17134849 Paper 16966192 Paper 16839698 Paper 16822120 Paper 16755537 Paper 16713126 Paper 15370932 Paper 15345275 Paper 15039761 Paper 14732428 Paper 11853135 Paper 11593078 Paper 11418225 Paper 11316375 Paper 10940546

Abstract

Over the last 4 years since the funding of this project, the UT Houston SAR-MDC has shown that cocaine dependence is associated with behavioral deficits including decision-making, behavioral inhibition, and the broader clinical construct of impulsivity. Likewise, we found differences between cocaine dependent subjects and non-drug using controls on Magnetic Resonance Imaging (MRI) measures of brain structure and function. In addition, we have acquired data showing that within cocaine users there is an association between these behavioral deficits and alterations in brain structure, brain function, and poor treatment response. For the renewal of this project, the focus will advance to determining the specific role of these brain MRI findings in treatment outcome by means of a carefully chosen battery of functional and structural MRI techniques in order to predict treatment response to specific classes of medication based on mechanism of action. Our previous blood oxygen level dependent (BOLD) fMRI data showed that cocaine dependent subjects (relative to controls) have (1) less dorsolateral prefrontal cortical, striatal, and thalamic activation during a working memory task, possibly reflecting impaired dopamine function;(2) greater activation in medial orbitofrontal cortex during impulsive responding on a Go-Nogo task, possibly reflecting impaired serotonin function;and (3) greater activation in medial orbitofrontal cortex and medial frontal cortex after negative feedback on a reversal learning task, also possibly reflecting impairment of serotonin function. In order to follow-up the treatment implications of this data, this project will examine (a) pretreatment brain activation on these tasks as predictors of neurotransmitter-specific treatment response, and (b) eariy changes (after three weeks of pharmacotherapy) in task-related fMRI activation as predictors of subsequent longer-term neurotransmitter-specific treatment response. In addition, the relationship between treatment response and measures of white-matter structural integrity as measured by diffusion tensor MRI (DTI) and magnetization transfer ratio MRI (MTR) will be examined.

View original record on NIH RePORTER →